Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 trial update evaluating pembrolizumab in combination with intravesical BCG solution for recurrent non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 clinical trial update evaluating radio-immunotherapy before cystectomy in locally advanced urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update investigating a bladder-sparing regimen of tislelizumab plus gemcitabine and cisplatin for PD-L1 positive muscle-invasi…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer [Phase 1, Phase 2]
Clinical trial evaluating adjuvant proton therapy or IMRT for bladder cancer has completed (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Confocal Laser Endomicroscopy in the Lower Urinary Tract
The study completed an evaluation of confocal laser endomicroscopy for assessing the lower urinary tract in patients with bladder cancer and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer [Phase 2]
Phase II trial of pazopanib in combination with weekly paclitaxel in refractory urothelial cancer has completed, with results posted on 2017…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder [NA]
Clinical trial update reporting completion of a study evaluating neoadjuvant dasatinib followed by radical cystectomy for urothelial carcino…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine and split-dose cisplatin plus sorafenib in chemotherapy-naïve urothelial carcinoma of the bladder. The …
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating sorafenib in advanced or metastatic urothelial cancers of the urinary tract (including bladder, renal pelvis, and u…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial evaluating VEGF Trap (aflibercept) in patients with recurrent, locally advanced, or metastatic urothelial cancers has comple…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Arsenic Trioxide in Treating Patients With Urothelial Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide in patients with recurrent urothelial cancers (including bladder, renal pelvis, ureter,…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating trastuzumab for previously treated, locally advanced or metastatic urothelial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Pazopanib and Vinflunine in Urothelial Cancer of the Bladder [Phase 1, Phase 2]
Phase 1/2 clinical trial update of pazopanib and vinflunine in advanced urothelial carcinoma of the bladder after platinum therapy failure; …
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer [Phase 2]
This document reports the completion and results posting of a Phase II study of AZD4877, an anti-mitotic agent, in advanced bladder cancer a…